Ronald Uszenski, MD
Interventional Cardiology · Mooresville, NCNPI 1447230099
Payments from drug & device makers
Across 584 payments — averaging $847.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$491K
- Boston Scientific$2K
- Amgen$256
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$251
- Novartis$218
- Abbott$200
- plus $922 from 18 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 482 | $491,168 |
| Boston Scientific | 16 | $1,914 |
| Amgen | 8 | $256 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 17 | $251 |
| Novartis | 12 | $218 |
| Abbott | 5 | $200 |
| E.r. Squibb & Sons, L.L.C. | 11 | $190 |
| Abiomed | 5 | $137 |
| Pfizer | 4 | $80 |
| Bayer | 4 | $70 |
| Sanofi-aventis U.S. LLC | 3 | $64 |
| Philips North America LLC | 3 | $60 |
| Alnylam Pharmaceuticals Inc. | 2 | $52 |
| Lexicon Pharmaceuticals, Inc. | 2 | $41 |
| Tactile Systems Technology Inc | 1 | $33 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $25 |
| Convatec Inc. | 1 | $25 |
| Kestra Medical Technology Services, Inc. | 1 | $25 |
| Edwards Lifesciences | 1 | $25 |
| Cvrx, Inc. | 1 | $22 |
| Bridgebio Pharma, Inc. | 1 | $20 |
| GSK | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $15 |
How this compares
$494,929 in reported general payments places this provider in the 85th percentile of 180 interventional cardiology providers in North Carolina.
See all interventional cardiology providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Mooresville
- Ravish SacharRaleigh$10.1M
- George AdamsGarner$5.2M
- Paul MahoneyGreenville$3.9M
- Oluseun AlliCharlotte$2.3M
- Patrick SimpsonPinehurst$1.6M
- Matthew CavenderChapel Hill$1.5M
- Rajesh SwaminathanDurham$1.4M
- Steven FilbyPinehurst$1.3M
- John PasquiniCharlotte$1.3M
- James ZidarRaleigh$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.